Biological mechanisms at moderate levels of alcohol consumption that may affect coronary heart disease

Bradley TD Phillipson EA. Pathogenesis and pathophysiology of the obstructive sleep apnea syndrome. Med Clin North Am 1985; 69: 1169–1185.

Colditz GA. A prospective assessment of moderate alcohol intake and major chronic diseases. AEP 1990; 1: 167–177.

Despres J.-P. The insulin resistance-dyslipidemia syndrome: The most prevalent cause of coronary artery disease. Can Med Assn J 1993; 148: 1339–1340.

Deykin D Janson P McMahon L. Ethanol potentiation of aspirin-induced prolongation of the bleeding time. N Eng J Med 1982; 306: 852–854.

Frankel EN Kanner J German JB Parks E Kinsella JE. Inhibition of oxidation of human low density lipoprotein by phenolic substances in red wine. Lancet 1993; 341: 454–457.

Friedman HS. Acute effects of ethanol on myocardial blood flow in the nonischemic and ischemic heart. Am J Cardiol 1981; 47: 61–67.

Fuster V Badimon L Badimon J Chesbro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (first of two parts). N Eng J Med 1992a; 326: 242–250.

Fuster V Badimon L Badimon J Chesbro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (second of two parts). N Eng J Med 1992b, 326: 310–318.

Hein HO Sorensen H Suadicani P Gyntelberg F. The Lewis blood group—a new genetic marker of ischemic heart disease. J Intern Med 1992; 232: 481–488.

Hein HO Sorensen H Suadicani P Gyntelberg F. Alcohol consumption, Lewis phenotypes, and risk of ischaemic heart disease. Lancet 1993; 341: 392–396.

Hung J Whitford EG Parsons RW Hillman DR. Association of sleep apnoea with myocardial infarction in men. Lancet 1990; 336: 261–264.

Issa FQ Sullivan CE. Alcohol, snoring and sleep apnoea. J Neurol Neurosurg Psychiatry 1983; 45: 353–359.

Kreisberg RA Segrest JP (eds). Plasma Lipoproteins and Coronary Artery Disease, Current Issues in Endocrinology and Metabolism. Blackwell Scientific Publications, Boston, 1993.

Landolfi R Steiner M. Ethanol raises prostacyclin in vivo and in vitro. Blood 1984; 64: 679–682.

McPherson R. Do antioxidant vitamins prevent coronary artery disease? Medicine North America 1993; March, 200–201.

Moller DE Flier JS. Insulin resistance—mechanisms, syndromes and implications. N Eng J Med 1991; 325: 938–948.

Quinn MT Parthasarathy S Steinberg D. Endothelial cell-derived chemotactic activity for mouse peritoneal macrophages and the effects of modified forms of low density lipoprotein. Proc Nat Acad Sci 1985; 82: 5949–5953.

Razay G Heatton KW Bolton CH Hughes AO. Alcohol consumption and its relation to cardiovascular risk factors in British women. BMJ 1992; 304: 80–83.

Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595–1607.

Renaud S de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992; 339: 1523–1526.

Russell JC Amy RM Manickave) V Dolphin PJ. Effects of chronic ethanol consumption and atherosclerosis-prone JCR: LA-corpulent rat. Arteriosclerosis 1989; 9: 122–128.

Siemann EH Creasy LL. Concentration of the phytoalexin resveratrol in wine. Am J Enol Vitic 1992; 43: 49–52.

Steinberg D Pearson TA Kuller LH. Alcohol and atherosclerosis. Ann Intern Med 1991; 114: 967–976.

Steinberg D Parthasarathy S Carew TE et al. Beyond cholesterol: Modification of low density lipoproteins that increases its atherogenicity. N Eng J Med 1989; 320: 915–924.

Veenstra J. Effects of alcohol on the cardiovascular system. In Alcohol and Cardiovascular Disease: Proceedings of an International Symposium, eds. Veenstra J , van der Heij TNO , Nutrition and Food Research, Zeist N, Pudoc Wageningen, 1992, 87–113.